These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14279210)

  • 1. IN VIVO ACTIVATION OF THE FIBRINOLYTIC SYSTEM OF THE CAT. EFFECT OF STREPTOKINASE, TRYPSIN AND GLYCEROL.
    FLEMING LB; CLIFFTON EE
    J Surg Res; 1965 Apr; 5():153-65. PubMed ID: 14279210
    [No Abstract]   [Full Text] [Related]  

  • 2. STUDIES ON THE RELATIONSHIP BETWEEN FIBRIN-STABILIZING FACTOR, CALCIUM AND INHIBITION OF FIBRINOLYSIS.
    TYLER HM; LACK CH
    Clin Sci; 1965 Jun; 28():527-36. PubMed ID: 14316258
    [No Abstract]   [Full Text] [Related]  

  • 3. EFFECTS OF FEMALE HORMONES, USED AS ORAL CONTRACEPTIVES, ON THE FIBRINOLYTIC SYSTEM IN BLOOD.
    BRAKMAN P; ASTRUP T
    Lancet; 1964 Jul; 2(7349):10-2. PubMed ID: 14149193
    [No Abstract]   [Full Text] [Related]  

  • 4. EFFECT OF GLYCEROL ON THE RESISTANCE OF BLOOD AND PLASMA CLOTS TO THE ACTION OF PROTEOLYTIC ENZYMES.
    ABEYARATNE MR; PORTER IA; WALDER DN
    Nature; 1964 Apr; 202():98-9. PubMed ID: 14166737
    [No Abstract]   [Full Text] [Related]  

  • 5. SOME PROPERTIES OF THE ANTIFIBRINOLYTICALLY ACTIVE ISOMER OF AMINO-METHYLCYCLOHEXANE CARBOXYLIC ACID.
    DUBBER AH; MCNICOL GP; DOUGLAS AS; MELANDER B
    Lancet; 1964 Dec; 2(7373):1317-9. PubMed ID: 14224037
    [No Abstract]   [Full Text] [Related]  

  • 6. ACTIVATION OF RABBIT PLASMINOGEN BY STREPTOKINASE.
    CHATTOPADHYAY DP; CLIFFTON EE
    Am J Physiol; 1965 Jan; 208():190-7. PubMed ID: 14253148
    [No Abstract]   [Full Text] [Related]  

  • 7. [THE FIBRINOLYTIC THERAPY OF EXPERIMENTAL MASSIVE PULMONARY EMBOLISM IN RABBITS].
    MATTIOLI G; RABITTI G; NAVA C
    Minerva Cardioangiol; 1964 Jan; 12():25-8. PubMed ID: 14130219
    [No Abstract]   [Full Text] [Related]  

  • 8. STUDIES ON THE ADMINISTRATION OF STREPTOKINASE. A METHOD TO OBTAIN THROMBOLYTIC EFFECT WITHOUT EXCESSIVE FIBRINOGENOLYSIS.
    HELLE I; AAS K; GODAL HC
    Sangre (Barc); 1964; 38():167-74. PubMed ID: 14217607
    [No Abstract]   [Full Text] [Related]  

  • 9. EFFECTS OF FIBRINOLYTIC AGENTS AND HEPARIN ON BLOOD COAGULATION IN DOGS.
    LEWIS JH; SHIRAKAWA M
    Am J Physiol; 1964 Nov; 207():1049-52. PubMed ID: 14237448
    [No Abstract]   [Full Text] [Related]  

  • 10. [EFFECT OF FIBRINOLYTIC ACTION FOUND IN ASCITES OF EHRLICH CANCER CELL IN MICE].
    HIRATA T
    Kobe Ika Daigaku Kiyo; 1963 Dec; 25():1-9. PubMed ID: 14117791
    [No Abstract]   [Full Text] [Related]  

  • 11. [THE ACTION OF THROMBIN ON THE FROG HEART].
    MARKWARDT F; HAUSTEIN KO; NUERNBERGK W
    Thromb Diath Haemorrh; 1964 Oct; 12():262-8. PubMed ID: 14224637
    [No Abstract]   [Full Text] [Related]  

  • 12. EXPERIMENTAL IN VITRO STUDIES ON THE LYSIS OF BLOOD-CLOT.
    DUNSTONE GH; FLEMING LB; PORTER IA; WALDER DN
    Br J Surg; 1964 Mar; 51():227-34. PubMed ID: 14129442
    [No Abstract]   [Full Text] [Related]  

  • 13. [Research on fibrinolysis: the fibrinolysis factors in Kline's plasminogen].
    GIACOMAZZI G
    Haematol Lat; 1961; 4():339-70. PubMed ID: 13898267
    [No Abstract]   [Full Text] [Related]  

  • 14. FIBRINOLYSIS AND THE PLASMA PROTEIN ELECTROPHORETIC PATTERN.
    BIELAWIEC M; NILSSON IM
    Scand J Clin Lab Invest; 1964; 16():513-20. PubMed ID: 14209211
    [No Abstract]   [Full Text] [Related]  

  • 15. [EFFECT OF INCREASED FIBRINOLYSIS ON PLASMA FIBRINOGEN; A HYPOTHESIS CONCERNING THE ORIGIN OF AFIBRINOGENEMIA].
    DE WIT CD; MOERS AM; DEN OTTOLANDERGJ
    Ned Tijdschr Geneeskd; 1964 Aug; 108():1482-5. PubMed ID: 14182799
    [No Abstract]   [Full Text] [Related]  

  • 16. THE INHIBITION OF TRASYLOL OF FIBRINOLYTIC ACTIVITY ASSOCIATED WITH CARDIOVASCULAR OPERATIONS.
    TICE DA; WORTH MH; CLAUSS RH; REED GH
    Surg Gynecol Obstet; 1964 Jul; 119():71-4. PubMed ID: 14179354
    [No Abstract]   [Full Text] [Related]  

  • 17. FIBRINOGEN BREAKDOWN PRODUCTS.
    LEWIS JH; WILSON JH
    Am J Physiol; 1964 Nov; 207():1053-7. PubMed ID: 14237449
    [No Abstract]   [Full Text] [Related]  

  • 18. THE INFLUENCE OF FIBRINOGENOLYTIC AND FIBRINOLYTIC SPLIT PRODUCTS ON THE LAST STAGE OF COAGULATION.
    GODAL HC; HELLE I
    Scand J Clin Lab Invest; 1963; 15():327-30. PubMed ID: 14073280
    [No Abstract]   [Full Text] [Related]  

  • 19. [TRYPSIN-CHYMOTRYPSIN IN THE VASCULAR OCCLUSIVE PROCESSES].
    MOSSO HE; PERGOLA F; MARCEILLAC E
    Prensa Med Argent; 1963 Apr; 50():1081-4. PubMed ID: 14089189
    [No Abstract]   [Full Text] [Related]  

  • 20. ENHANCING BLOOD FIBRINOLYTIC ACTIVITY BY A NIACIN COMPOUND. II. ACTIVATION AND NONACTIVATION.
    AMERY A; VERMYLEN J; DEVREKER RA; VERMYLEN C
    Am J Med Sci; 1965 Jan; 249():66-71. PubMed ID: 14254831
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.